MAPT and neurodegenerative disease: Identification of the most effective tau epitopes for vaccine development is still a matter of debate since many modifications of tau (phosphorylation, truncation, oligomerization, etc.)have been demonstrated to contribute to neurodegenerative disease pathogenesis.